European Urology Oncology

Displaying 1 - 2 of 2
Alsaied, T., Li, R., Christopher, A. B., Fogel, M., Slesnick, T. C., Krishnamurthy, R., Muthurangu, V., Dorfman, A. L., Lam, C. Z., Weigand, J. D., Jeong, J.-H., Robinson, J. D., Olivieri, L. J., Rathod, R. H., Loke, Y.-H., Stern, K., Soslow, J. H., Aggarwal, M., Johnson, T., … Raimondi, F. (2024). Characterization and z-score calculation of cardiovascular magnetic resonance imaging parameters in patients after the Fontan operation: A Fontan Outcome Registry using Cardiovascular Magnetic Resonance Examinations study. Journal of Cardiovascular Magnetic Resonance, 26(2), 101113. https://doi.org/10.1016/j.jocmr.2024.101113
Publication Date
Gorin, M. A., Patel, H. D., Rowe, S. P., Hahn, N. M., Hammers, H. J., Pons, A., Trock, B. J., Pierorazio, P. M., Nirschl, T. R., Salles, D. C., Stein, J. E., Lotan, T. L., Taube, J. M., Drake, C. G., & Allaf, M. E. (2022). Neoadjuvant Nivolumab in Patients with High-risk Nonmetastatic Renal Cell Carcinoma. European Urology Oncology, 5(1), 113–117. https://doi.org/10.1016/j.euo.2021.04.002
Publication Date